CliffBio
small molecule

ATOMOXETINE HYDROCHLORIDE

ATOMOXETINE HYDROCHLORIDE

Loss of exclusivity—loss of exclusivity
CompanyApotex →See this company's full patent-cliff portfolio

Drug detail

Brand nameATOMOXETINE HYDROCHLORIDE
Active ingredientATOMOXETINE HYDROCHLORIDE
StrengthEQ 100MG BASE
Dosage formCAPSULE
RouteORAL
ModalitySmall molecule
FDA approvalMay 2017
Marketing statusRX

More from Apotex

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the loss of exclusivity; estimates are projections, not legal advice.